France
· Delayed Price · Currency is EUR Amplitude Surgical Statistics
Total Valuation
Amplitude Surgical has a market cap or net worth of EUR 154.52 million. The enterprise value is 236.04 million.
| Market Cap | 154.52M |
| Enterprise Value | 236.04M |
Important Dates
The next estimated earnings date is Monday, September 2, 2024.
| Earnings Date | Sep 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Amplitude Surgical has 47.99 million shares outstanding. The number of shares has increased by 2.53% in one year.
| Shares Outstanding | 47.99M |
| Shares Change (YoY) | +2.53% |
| Shares Change (QoQ) | -3.40% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | n/a |
| Float | 11.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.49 |
| PB Ratio | 1.63 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.35, with an EV/FCF ratio of -60.96.
| EV / Earnings | 5.46 |
| EV / Sales | 2.27 |
| EV / EBITDA | 10.35 |
| EV / EBIT | 22.22 |
| EV / FCF | -60.96 |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 119.21.
| Current Ratio | 2.17 |
| Quick Ratio | 1.16 |
| Debt / Equity | 119.21 |
| Debt / EBITDA | 4.95 |
| Debt / FCF | -29.15 |
| Interest Coverage | 0.98 |
Financial Efficiency
Return on equity (ROE) is -4.93% and return on invested capital (ROIC) is 3.35%.
| Return on Equity (ROE) | -4.93% |
| Return on Assets (ROA) | 2.52% |
| Return on Capital (ROIC) | 3.35% |
| Revenue Per Employee | 250,115 |
| Profits Per Employee | 103,911 |
| Employee Count | 416 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.40% in the last 52 weeks. The beta is 0.52, so Amplitude Surgical's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -6.40% |
| 50-Day Moving Average | 3.20 |
| 200-Day Moving Average | 3.20 |
| Relative Strength Index (RSI) | 61.33 |
| Average Volume (20 Days) | 340 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amplitude Surgical had revenue of EUR 104.05 million and earned 43.23 million in profits. Earnings per share was 0.90.
| Revenue | 104.05M |
| Gross Profit | 52.37M |
| Operating Income | 10.62M |
| Pretax Income | -2.83M |
| Net Income | 43.23M |
| EBITDA | 21.37M |
| EBIT | 10.62M |
| Earnings Per Share (EPS) | 0.90 |
Balance Sheet
The company has 31.34 million in cash and 112.86 million in debt, giving a net cash position of -81.52 million or -1.70 per share.
| Cash & Cash Equivalents | 31.34M |
| Total Debt | 112.86M |
| Net Cash | -81.52M |
| Net Cash Per Share | -1.70 |
| Equity (Book Value) | 94.67M |
| Book Value Per Share | 1.97 |
| Working Capital | 50.00M |
Cash Flow
In the last 12 months, operating cash flow was 7.98 million and capital expenditures -11.85 million, giving a free cash flow of -3.87 million.
| Operating Cash Flow | 7.98M |
| Capital Expenditures | -11.85M |
| Free Cash Flow | -3.87M |
| FCF Per Share | -0.08 |
Margins
Gross margin is 50.33%, with operating and profit margins of 10.21% and 41.55%.
| Gross Margin | 50.33% |
| Operating Margin | 10.21% |
| Pretax Margin | -2.72% |
| Profit Margin | 41.55% |
| EBITDA Margin | 20.54% |
| EBIT Margin | 10.21% |
| FCF Margin | -3.72% |
Dividends & Yields
Amplitude Surgical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.53% |
| Shareholder Yield | -2.53% |
| Earnings Yield | 27.95% |
| FCF Yield | -2.51% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |